Petmed Express Inc (PETS) Given Consensus Rating of “Hold” by Brokerages
Shares of Petmed Express Inc (NASDAQ:PETS) have been assigned a consensus rating of “Hold” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have issued a hold rating and three have assigned a buy rating to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $42.80.
Several research firms have weighed in on PETS. BidaskClub raised Petmed Express from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 9th. ValuEngine upgraded Petmed Express from a “hold” rating to a “buy” rating in a research note on Wednesday, February 7th. Finally, Northcoast Research set a $58.00 price target on Petmed Express and gave the company a “buy” rating in a research note on Wednesday, January 3rd.
Petmed Express (PETS) opened at $46.75 on Monday. The company has a market capitalization of $963.10, a price-to-earnings ratio of 27.66, a price-to-earnings-growth ratio of 2.64 and a beta of 0.93. Petmed Express has a one year low of $19.21 and a one year high of $57.80.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 16th. Stockholders of record on Monday, February 5th were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.14%. This is a boost from Petmed Express’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend was Friday, February 2nd. Petmed Express’s dividend payout ratio (DPR) is presently 59.17%.
In other Petmed Express news, CEO Menderes Akdag sold 30,000 shares of the firm’s stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $51.00, for a total transaction of $1,530,000.00. Following the transaction, the chief executive officer now owns 490,000 shares in the company, valued at approximately $24,990,000. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Ronald J. Korn sold 5,000 shares of the firm’s stock in a transaction on Monday, January 29th. The stock was sold at an average price of $48.38, for a total value of $241,900.00. Following the transaction, the director now owns 68,833 shares in the company, valued at approximately $3,330,140.54. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 65,000 shares of company stock valued at $3,229,500. Insiders own 4.00% of the company’s stock.
Several institutional investors and hedge funds have recently modified their holdings of the company. Elkfork Partners LLC bought a new position in shares of Petmed Express in the 4th quarter valued at $100,000. MetLife Investment Advisors LLC bought a new stake in Petmed Express during the 4th quarter worth $429,000. BB&T Securities LLC bought a new stake in Petmed Express during the 4th quarter worth $254,000. Municipal Employees Retirement System of Michigan grew its position in Petmed Express by 23.5% during the 4th quarter. Municipal Employees Retirement System of Michigan now owns 20,790 shares of the company’s stock worth $945,000 after acquiring an additional 3,960 shares during the last quarter. Finally, LPL Financial LLC bought a new stake in Petmed Express during the 4th quarter worth $238,000. Institutional investors own 91.30% of the company’s stock.
Petmed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for Petmed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Petmed Express and related companies with MarketBeat.com's FREE daily email newsletter.